Live from the NIH registry
Studies recruiting near Buffalo right now
Top 25 of 516 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Erie County Medical Center ( Site 0175) — Buffalo, New York (1.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Buffalo, New York (1.8 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Buffalo General Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Magenta Medical Ltd.
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Roswell Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 1
Interventional 126 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
Dent Neurological Institute — Buffalo, New York (1.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Dent Neurologic Institute - Amherst /ID# 270260 — Amherst, New York (5.8 mi)
· Sponsor: AbbVie
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Sisters of Charity Hospital — Buffalo, New York (1.8 mi)
· Sponsor: Duke University
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
University of Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: Edwards Lifesciences
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
The Cystic Fibrosis Center of Western New York — Buffalo, New York (1.8 mi)
· Sponsor: Nicole Hamblett
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
University of Buffalo Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Aneurysm
N/A
Interventional 10 participants sought
Jacobs Institute — Buffalo, New York (1.8 mi)
· Sponsor: Jacobs institute
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Peripheral Neuropathies, Peripheral Neuropathy Due to Chemotherapy
N/A
Interventional 200 participants sought
Dent Neurologic Institute — Amherst, New York (5.8 mi)
· Sponsor: RxFunction Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Roswell Park Cancer Institute ( Site 0023) — Buffalo, New York (1.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Advanced Solid Tumor, Melanoma
Phase 2
Interventional 740 participants sought
Roswell Park Cancer Institute IDS — Buffalo, New York (1.8 mi)
· Sponsor: Daiichi Sankyo
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Research Foundation of SUNY - University of Buffalo /ID# 261019 — Buffalo, New York (1.8 mi)
· Sponsor: AbbVie
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
VA Western New York Healthcare system — Buffalo, New York (1.8 mi)
· Sponsor: Synairgen Research Ltd.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
State University of New York at Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: Kura Oncology, Inc.
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
Extensive Stage Lung Small Cell Carcinoma
Phase 2
Interventional 28 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Roswell Park Cancer Institute
PUSH-IT Continuing Enteral Feeds for Tracheostomy
Tracheostomy Complication, Critical Illness
N/A
Interventional 200 participants sought
Erie County Medical Center (University at Buffalo) — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Phase 2, Phase 3
Interventional 470 participants sought
Local Institution - 0248 — Buffalo, New York (1.8 mi)
· Sponsor: Bristol-Myers Squibb